- Acute on Chronic Liver Failure SIG: Management of the Critically Ill Cirrhotic Patient: Improving Multidisciplinary Care and Avoiding…
- Alcoholic Liver Disease SIG: Alcoholic Hepatitis: New Therapeutic Strategies Beyond Prednisolone
- Cholestatic and Biliary Diseases SIG: Novel Treatment Approached to Cholestatic Liver Diseases: Theory and Practice
- Clinical Practice SIG: Best Practices in Clinical Hepatology
- HCV 2017 Treatment Symposium
- Hepatitis B SIG: Getting to HBV Cure: The Path Forward
- Hepatitis C SIG: HCV Treatment in Persons Who Inject Drugs
- Hepatobiliary Neoplasia SIG: HCV Therapy and HCC
- Hepatotoxicity SIG: Drig-Induced Liver Injury Due to Chemotherapeutic Agents
- Liver Cell Biology in Hepatic Diseases SIG: DAMPs and New Receptor Signaling in Liver Disease
- Liver Transplantation and Surgery Transplant SIG: Advances in Hepatocellular Carcinoma Therapy
- NAFLD SIG: Non-Invasive Diagnosis of NASH: We're getting There
- Pediatric Liver Disease SIG: Drug Induced Liver Injury in Children: Causes, Criteria, and Complications
- Portal Hypertension SIG: Critical Review of Invasive Interventions in Patients with Portal Hypertension
- Public Health/Healthcare Delivery SIG: Methods for Conducting Healthare Delivery Research
